Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells-Reference-Cited by-同舟云学术

Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells

Published:2024-01-25 Issue:3 Volume:34 Page:489-506
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Gao Yu¹^ORCID,Shelling Andrew N.²^ORCID,Nolan Emma³^ORCID,Porter David⁴^ORCID,Leung Euphemia³^ORCID,Wu Zimei¹^ORCID

Affiliation:

1. Faculty of Medical and Health Sciences, School of Pharmacy, The University of Auckland, Auckland, New Zealand

2. Faculty of Medical and Health Sciences, School of Medicine, The University of Auckland, Auckland, New Zealand

3. Faculty of Medical and Health Sciences, Auckland Cancer Society Research Centre, The University of Auckland, Auckland, New Zealand

4. Auckland Regional Cancer and Blood Service, Auckland City Hospital, Auckland, New Zealand

Funder

New Zealand Pharmacy Education and Research Foundation

University of Auckland

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2024.2305866

Reference82 articles.

1. Ferlay J Ervik M Colombet M et al. 2020. Global cancer observatory: cancer today. [online]. Lyon: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today

2. Breast Cancer: Current Perspectives on the Disease Status

3. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance

4. Prospective identification of tumorigenic breast cancer cells

5. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05